iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Stock Short Interest Jumps 61.1%

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 30th, there was short interest totaling 429,057 shares, a growth of 61.1% from the October 15th total of 266,270 shares. Based on an average daily volume of 257,701 shares, the short-interest ratio is currently 1.7 days. Approximately 2.8% of the company’s stock are short sold.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Several hedge funds and other institutional investors have recently modified their holdings of IHE. Fisher Asset Management LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the third quarter worth $271,848,000. MinichMacGregor Wealth Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $32,098,000. McElhenny Sheffield Capital Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter valued at about $13,201,000. Cetera Investment Advisers boosted its holdings in iShares U.S. Pharmaceuticals ETF by 675.4% during the first quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after purchasing an additional 95,353 shares during the last quarter. Finally, Virtue Capital Management LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $6,239,000.

iShares U.S. Pharmaceuticals ETF Trading Down 1.3%

IHE stock traded down $1.39 during mid-day trading on Monday, hitting $109.64. The stock had a trading volume of 155,158 shares, compared to its average volume of 177,916. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of 33.66 and a beta of 0.47. The company has a fifty day moving average of $103.18 and a 200 day moving average of $95.97. iShares U.S. Pharmaceuticals ETF has a 1-year low of $80.25 and a 1-year high of $112.29.

iShares U.S. Pharmaceuticals ETF Company Profile

(Get Free Report)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Recommended Stories

Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.